CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CANbridge Pharmaceuticals Inc. has announced its board composition, including Executive Director Dr. James Qun Xue as Chairman and CEO, alongside a list of Non-executive and Independent Non-executive Directors. The company’s board includes three key committees: Audit, Remuneration, and Nomination and Corporate Governance, with various members serving as chairpersons and committee members.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.